Arginase 2 deletion reduces Neuro-Glial injury and improves retinal function in a model of Retinopathy of prematurity

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Narayanan, Subhadra P ^a   Suwanpradid, Jutamas ^a   Saul, Alan ^a   Xu, Zhimin ^a   Still, Amber ^a   Caldwell, Robert W ^a   Caldwell, Ruth B ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 2; BIM PROTEIN; CASPASE 9; CYTOCHROME C; HYDROLASE; PROTEIN BCL XL; PROTEIN P53; UNCLASSIFIED DRUG; ARG2 PROTEIN, MOUSE; ARGINASE; OXYGEN;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B WAVE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; GENE DELETION; GLIA CELL; MOUSE; NERVE CELL LESION; NONHUMAN; PROTEIN CLEAVAGE; RETINA BIPOLAR GANGLION CELL; RETROLENTAL FIBROPLASIA; WILD TYPE; ANIMAL; CELL PROTECTION; DISEASE MODEL; ENZYMOLOGY; GLIA; HUMAN; METABOLISM; NERVE CELL; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA; RETINA DEGENERATION; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; APOPTOSIS; ARGINASE; CASPASE 9; CYTOPROTECTION; DISEASE MODELS, ANIMAL; GENE DELETION; HUMANS; INFANT, NEWBORN; MICE; NEUROGLIA; NEURONS; OXYGEN; RETINA; RETINAL BIPOLAR CELLS; RETINAL DEGENERATION; RETINOPATHY OF PREMATURITY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79960633986     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022460     Document Type: Article

References (43)

1. Fletcher EL, Downie LE, Hatzopoulos K, Vessey KA, Ward MM, et al. (2010) The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy. Doc Ophthalmol 120: 67-86.
2. Fulton AB, Hansen RM, Moskowitz A, Akula JD, (2009) The neurovascular retina in retinopathy of prematurity. Prog Retin Eye Res 28: 452-482.
3. Barnaby AM, Hansen RM, Moskowitz A, Fulton AB, (2007) Development of scotopic visual thresholds in retinopathy of prematurity. Invest Ophthalmol Vis Sci 48: 4854-4860.
4. Fulton AB, Hansen RM, (1996) Photoreceptor function in infants and children with a history of mild retinopathy of prematurity. J Opt Soc Am A Opt Image Sci Vis 13: 566-571.
5. Fulton AB, Hansen RM, Petersen RA, Vanderveen DK, (2001) The rod photoreceptors in retinopathy of prematurity: an electroretinographic study. Arch Ophthalmol 119: 499-505.
6. O'Connor AR, Stephenson T, Johnson A, Tobin MJ, Moseley MJ, et al. (2002) Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity. Pediatrics 109: 12-18.
7. Hansen RM, Fulton AB, (2000) Background adaptation in children with a history of mild retinopathy of prematurity. Invest Ophthalmol Vis Sci 41: 320-324.
8. Akula JD, Mocko JA, Benador IY, Hansen RM, Favazza TL, et al. (2008) The neurovascular relation in oxygen-induced retinopathy. Mol Vis 14: 2499-2508.
9. Akula JD, Hansen RM, Tzekov R, Favazza TL, Vyhovsky TC, et al. Visual cycle modulation in neurovascular retinopathy. Exp Eye Res.
10. Sennlaub F, Courtois Y, Goureau O, (2001) Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy. J Clin Invest 107: 717-725.
11. Sennlaub F, Courtois Y, Goureau O, (2002) Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. J Neurosci 22: 3987-3993.
12. Downie LE, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Fletcher EL, (2007) Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity. J Comp Neurol 504: 404-417.
13. Gu X, Samuel S, El-Shabrawey M, Caldwell RB, Bartoli M, et al. (2002) Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 43: 496-502.
14. Durante W, Johnson FK, Johnson RA, (2007) Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34: 906-911.
15. Stevenson L, Matesanz N, Colhoun L, Edgar K, Devine A, et al. Reduced nitro-oxidative stress and neural cell death suggests a protective role for microglial cells in TNFalpha-/- mice in ischemic retinopathy.Invest Ophthalmol Vis Sci 51: 3291-3299.
16. Cederbaum SD, Yu H, Grody WW, Kern RM, Yoo P, et al. (2004) Arginases I and II: do their functions overlap? Mol Genet Metab 81 (Suppl 1): S38-44.
17. Zhang W, Baban B, Rojas M, Tofigh S, Virmani SK, et al. (2009) Arginase activity mediates retinal inflammation in endotoxin-induced uveitis. Am J Pathol 175: 891-902.
18. Braissant O, Gotoh T, Loup M, Mori M, Bachmann C, (1999) L-arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization study. Brain Res Mol Brain Res 70: 231-241.
19. Tian N, (2004) Visual experience and maturation of retinal synaptic pathways. Vision Res 44: 3307-3316.
20. Downie LE, Hatzopoulos KM, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, et al. (2010) Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity. J Comp Neurol 518: 41-63.
21. Fulton AB, Hansen RM, Moskowitz A, Barnaby AM, (2005) Multifocal ERG in subjects with a history of retinopathy of prematurity. Doc Ophthalmol 111: 7-13.
22. Liu K, Akula JD, Hansen RM, Moskowitz A, Kleinman MS, et al. (2006) Development of the electroretinographic oscillatory potentials in normal and ROP rats. Invest Ophthalmol Vis Sci 47: 5447-5452.
23. Culmsee C, Mattson MP, (2005) p53 in neuronal apoptosis. Biochem Biophys Res Commun 331: 761-777.
24. Hetman M, Vashishta A, Rempala G, (2010) Neurotoxic mechanisms of DNA damage: focus on transcriptional inhibition. J Neurochem 114: 1537-1549.
25. Hong LZ, Zhao XY, Zhang HL, (2005) p53-mediated neuronal cell death in ischemic brain injury. Neurosci Bull 26: 232-240.
26. Dembinska O, Rojas LM, Varma DR, Chemtob S, Lachapelle P, (2001) Graded contribution of retinal maturation to the development of oxygen-induced retinopathy in rats. Invest Ophthalmol Vis Sci 42: 1111-1118.
27. Lachapelle P, Dembinska O, Rojas LM, Benoit J, Almazan G, et al. (1999) Persistent functional and structural retinal anomalies in newborn rats exposed to hyperoxia. Can J Physiol Pharmacol 77: 48-55.
28. Kolb H, Fernandez E, Nelson R, (1995) Webvision: The Organization of the Retina and Visual System (Internet). Salt Lake City (UT) University of Utah Health Sciences Center.
29. Eldred WD, Blute TA, (2005) Imaging of nitric oxide in the retina. Vision Res 45: 3469-3486.
30. Yang XL, (2004) Characterization of receptors for glutamate and GABA in retinal neurons. Prog Neurobiol 73: 127-150.
31. Yu H, Iyer RK, Kern RM, Rodriguez WI, Grody WW, et al. (2001) Expression of arginase isozymes in mouse brain. J Neurosci Res 66: 406-422.
32. Pernet V, Bourgeois P, Di Polo A, (2007) A role for polyamines in retinal ganglion cell excitotoxic death. J Neurochem 103: 1481-1490.
33. Lau A, Tymianski M Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 460: 525-542.
34. Neufeld AH, Kawai S, Das S, Vora S, Gachie E, et al. (2002) Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase. Exp Eye Res 75: 521-528.
35. Sakamoto K, Yonoki Y, Kubota Y, Kuwagata M, Saito M, et al. (2006) Inducible nitric oxide synthase inhibitors abolished histological protection by late ischemic preconditioning in rat retina. Exp Eye Res 82: 512-518.
36. Ivanova S, Batliwalla F, Mocco J, Kiss S, Huang J, et al. (2002) Neuroprotection in cerebral ischemia by neutralization of 3-aminopropanal. Proc Natl Acad Sci U S A 99: 5579-5584.
37. Takano K, Ogura M, Nakamura Y, Yoneda Y, (2005) Neuronal and glial responses to polyamines in the ischemic brain. Curr Neurovasc Res 2: 213-223.
38. Wood PL, Khan MA, Kulow SR, Mahmood SA, Moskal JR, (2006) Neurotoxicity of reactive aldehydes: the concept of "aldehyde load" as demonstrated by neuroprotection with hydroxylamines. Brain Res 1095: 190-199.
39. Sass G, Shembade ND, Haimerl F, Lamoureux N, Hashemolhosseini S, et al. (2007) TNF pretreatment interferes with mitochondrial apoptosis in the mouse liver by A20-mediated down-regulation of Bax. J Immunol 179: 7042-7049.
40. Shi O, Morris SM Jr, Zoghbi H, Porter CW, O'Brien WE, (2001) Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene. Mol Cell Biol 21: 811-813.
41. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, et al. (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35: 101-111.
42. Bartoli M, Al-Shabrawey M, Labazi M, Behzadian MA, Istanboli M, et al. (2009) HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 50: 4934-4940.
43. Romero MJ, Platt DH, Tawfik HE, Labazi M, El-Remessy AB, et al. (2008) Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 102: 95-102.